An 18-year-old female presents with a complaint of recurrent acne on her face and neck. Which of the following is the preferred topical drug for treatment?
The condition seen in the illustration is:

A patient presented with multiple nodulocystic lesions on the face. Which is the drug of choice for this condition?
A 50-year-old female presents with lesions on her cheek, chin, and forehead. On examination, the skin is erythematous with dilated blood vessels, nodules, and pustules, but no comedones. What is the most likely diagnosis?
A young person presents with comedones and papulo-pustular acne affecting the face, trunk, and back. What is the recommended management approach for this patient?
Which of the following is NOT a causative factor for acne?
Oral retinoid is indicated in the treatment of which condition?
A 17-year-old male is to be started on oral isotretinoin. What parameter should be measured before instituting therapy?
A teenage girl presented in OPD with moderate acne and a history of irregular menses. What treatment would you suggest?
Acne vulgaris primarily involves which structure?
Explanation: ### Explanation **Correct Option: A. Minocycline** The primary goal in treating acne with topical or systemic antibiotics is to target *Cutibacterium acnes* (formerly *Propionibacterium acnes*) and utilize anti-inflammatory properties. Among the tetracycline class, **Minocycline** is highly lipophilic, allowing it to penetrate the lipid-rich sebaceous follicles more effectively than other derivatives. While the question asks for a "topical drug," it is important to note that in clinical practice, Minocycline is traditionally used systemically. However, **Topical Minocycline (4% foam/gel)** has recently gained FDA approval and is preferred in modern dermatology because it offers high efficacy with a significantly lower risk of systemic side effects (like vestibular toxicity or pigmentation) compared to its oral counterpart. **Why other options are incorrect:** * **B. Oxytetracycline:** This is a first-generation tetracycline. It is less lipophilic, has poor skin penetration, and requires frequent dosing (empty stomach), making it less effective for acne compared to newer agents. * **C. Demeclocycline:** Primarily used for treating SIADH (due to its ability to induce nephrogenic diabetes insipidus). It is rarely used for acne due to its high potential for severe phototoxicity. * **D. Doxycycline:** While Doxycycline is the **most common oral antibiotic** used for acne due to its cost-effectiveness and safety profile, Minocycline is technically superior in terms of follicular penetration and anti-inflammatory potency. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC) for Mild Acne:** Topical Retinoids + Benzoyl Peroxide. * **DOC for Severe Nodulocystic Acne:** Oral Isotretinoin. * **Side Effect Highlight:** Minocycline can cause **blue-grey skin/mucosal pigmentation** and drug-induced lupus. * **Counseling:** Always advise patients to avoid taking tetracyclines with milk or antacids, as they chelate with calcium/magnesium, reducing absorption.
Explanation: ***Glandular form of acne rosacea*** - This represents **rhinophyma**, the **phymatous/glandular form** of acne rosacea characterized by **sebaceous hyperplasia** and tissue overgrowth on the nose. - Typically presents as a **bulbous, enlarged nose** with prominent pores and **erythematous, thickened skin** in middle-aged to older adults. *A form of acne vulgaris* - **Acne vulgaris** primarily affects adolescents and young adults with **comedones, papules, and pustules** on face, chest, and back. - Unlike rhinophyma, acne vulgaris does not cause **tissue hypertrophy** or the characteristic **bulbous nasal deformity**. *Affects the scalp* - **Rhinophyma** specifically affects the **nasal area** and does not involve the scalp region. - **Scalp involvement** would suggest other conditions like **seborrheic dermatitis** or **folliculitis**, not rosacea variants. *A form of dermatofibroma* - **Dermatofibroma** is a benign **fibrous nodule** that typically appears as a **firm, brown papule** on extremities. - It lacks the **vascular component**, **sebaceous hyperplasia**, and **nasal location** characteristic of rhinophyma.
Explanation: **Explanation:** The patient presents with **Nodulocystic Acne**, which is classified as **Grade IV (Severe) Acne**. **1. Why Retinoids are the Correct Choice:** Oral **Isotretinoin** (a systemic retinoid) is the drug of choice for severe nodulocystic acne. It is the only medication that addresses all four pathogenic factors of acne: * **Follicular hyperkeratinization:** It normalizes keratinization, preventing comedone formation. * **Sebum production:** It significantly reduces the size and activity of sebaceous glands. * ***Cutibacterium acnes* colonization:** By reducing sebum (the bacteria's food source), it decreases bacterial load. * **Inflammation:** It possesses potent anti-inflammatory properties. **2. Why Other Options are Incorrect:** * **Antibiotics:** While oral tetracyclines (like Doxycycline) are used for Grade II and III acne, they are insufficient as monotherapy for nodulocystic lesions and do not prevent permanent scarring. * **Steroids:** Systemic steroids are not the primary treatment. They are used briefly as an adjunct in **Acne Fulminans** or to reduce "flare-ups" when starting Isotretinoin, but they do not treat the underlying pathology. * **UV Light:** Phototherapy has limited efficacy in acne. While it may have mild antibacterial effects, it is not a standard or first-line treatment for severe cystic cases. **Clinical Pearls for NEET-PG:** * **Teratogenicity:** Isotretinoin is highly teratogenic (Category X). Female patients must follow the **iPLEDGE** program or similar protocols (two forms of contraception and monthly pregnancy tests). * **Monitoring:** Check baseline Lipid Profile and Liver Function Tests (LFTs), as Isotretinoin can cause hypertriglyceridemia and transaminitis. * **Common Side Effect:** Cheilitis (dryness of lips) is the most common side effect, seen in nearly 100% of patients. * **Drug Interaction:** Never co-administer Isotretinoin with Tetracyclines due to the risk of **Pseudotumor Cerebri** (Benign Intracranial Hypertension).
Explanation: ### Explanation The correct diagnosis is **Rosacea**. This clinical presentation highlights the classic triad of rosacea: **erythema, telangiectasia (dilated blood vessels), and inflammatory lesions (papules/pustules)** involving the central face (cheeks, chin, forehead). The most critical diagnostic feature in this case is the **absence of comedones**. Rosacea is often called "adult acne," but unlike Acne Vulgaris, it is not a disorder of the pilosebaceous follicle involving hyperkeratinization; therefore, comedones (blackheads/whiteheads) are never present. The presence of nodules and pustules in a middle-aged female further supports the diagnosis of **Papulopustular Rosacea**. **Why other options are incorrect:** * **Folliculitis:** Usually presents as monomorphic pustules centered around hair follicles, often triggered by infection or friction, and lacks the background of telangiectasia and persistent facial erythema. * **Mild Acne Vulgaris:** While it presents with papules and pustules, it is characterized by the presence of **comedones** and typically occurs in a younger age group. * **Acne Conglobata:** This is a severe form of acne characterized by interconnecting abscesses, cysts, and significant scarring. It also features prominent comedones (often polyporous). **High-Yield Clinical Pearls for NEET-PG:** * **Triggers:** Rosacea is exacerbated by sunlight, spicy food, alcohol, and hot beverages. * **Demographics:** Most common in females aged 30–50 years. * **Phymatous changes:** Chronic rosacea can lead to **Rhinophyma** (bulbous nose due to sebaceous gland hyperplasia), which is more common in males. * **Ocular Rosacea:** Up to 50% of patients have eye involvement (blepharitis, conjunctivitis). * **Treatment:** Topical **Metronidazole** is the first-line treatment; systemic Tetracyclines (Doxycycline) are used for inflammatory lesions.
Explanation: This question tests the ability to classify acne severity and choose the appropriate pharmacological intervention based on standard treatment guidelines. ### **Explanation of the Correct Answer** The patient presents with **moderate to severe inflammatory acne** (papulo-pustular) involving multiple sites (face, trunk, and back). * **Systemic Involvement:** When acne affects large surface areas like the trunk and back, topical therapy alone is often impractical and insufficient. * **Combination Therapy:** The gold standard for moderate inflammatory acne is a combination of an **oral antibiotic** (to reduce *C. acnes* colonization and inflammation) and a **topical retinoid** (to target comedogenesis and normalize follicular keratinization). * **Doxycycline** is the preferred first-line oral tetracycline due to its efficacy and better safety profile compared to minocycline. ### **Analysis of Incorrect Options** * **A. Topical retinoic acid:** This is the first-line treatment for *mild comedonal* acne. It is insufficient as a monotherapy for inflammatory papulo-pustular lesions, especially with truncal involvement. * **C. Topical clindamycin:** While useful for mild inflammatory acne, it should never be used as monotherapy due to the high risk of bacterial resistance. It is typically combined with Benzoyl Peroxide (BPO). * **D. Oral retinoic acid (Isotretinoin):** This is reserved for **severe cystic/nodular acne**, scarring acne, or cases refractory to conventional systemic antibiotics. It is not the immediate first-line for standard papulo-pustular acne. ### **NEET-PG High-Yield Pearls** 1. **Drug of Choice (DOC):** Oral Isotretinoin is the DOC for **Acne Conglobata** and severe nodulocystic acne. 2. **Side Effects:** Doxycycline can cause **photosensitivity** and GI upset; it is contraindicated in pregnancy and children <8 years. 3. **Resistance Prevention:** Always combine topical/oral antibiotics with **Benzoyl Peroxide** to prevent the development of antibiotic resistance. 4. **Adverse Effect of Isotretinoin:** Most common is **cheilitis** (dry lips); most serious is **teratogenicity** (requires strict contraception/IPLEDGE).
Explanation: **Explanation:** Acne vulgaris is a chronic inflammatory disease of the pilosebaceous unit. The pathogenesis involves four primary factors: follicular hyperkeratinization, sebum production (androgen-mediated), colonization by *Cutibacterium acnes*, and inflammation. **Why "Dietary Factors" is the correct answer:** While historically debated, current medical consensus and standard textbooks (like Fitzpatrick) emphasize that **dietary factors** (such as chocolate, oily foods, or sweets) are not primary causative factors in the pathogenesis of acne. Although high-glycemic-index diets or dairy may exacerbate pre-existing acne in some individuals, they do not trigger the underlying pathophysiological process. **Analysis of other options:** * **Androgens (A):** These are crucial. Androgens (specifically DHT) stimulate sebaceous glands to increase sebum production, which is a prerequisite for acne development. * **Keratin (C):** Abnormal follicular **keratinization** leads to the formation of a "keratin plug" (microcomedo), which obstructs the pilosebaceous duct. * **Cell Nucleus (D):** This refers to the nuclear receptors (like Retinoic Acid Receptors or PPARs) involved in the differentiation of sebocytes and keratinocytes. Furthermore, the inflammatory cascade in acne involves nuclear transcription factors like **NF-κB**. **High-Yield Clinical Pearls for NEET-PG:** * **Primary lesion:** The **Microcomedo** is the earliest pathological lesion. * **Bacteria:** *Cutibacterium acnes* (formerly *Propionibacterium*) is a Gram-positive anaerobic rod. * **Drug of Choice:** Oral **Isotretinoin** is the only drug that acts on all four pathogenic mechanisms. * **Hormonal markers:** In females with recalcitrant acne, check for PCOS (increased LH/FSH ratio and DHEAS).
Explanation: **Explanation:** **Correct Option: A. Acne Vulgaris** Oral retinoids (specifically **Isotretinoin**) are the "gold standard" for severe, recalcitrant, or nodulocystic acne. Isotretinoin is unique because it is the only drug that targets all four pathogenic mechanisms of acne: 1. **Sebosuppression:** Reduces sebum production by inducing apoptosis of sebocytes. 2. **Comedolysis:** Normalizes follicular keratinization. 3. **Antibacterial:** Indirectly reduces *Cutibacterium acnes* by removing its food source (sebum). 4. **Anti-inflammatory:** Inhibits chemotaxis and inflammation. **Why other options are incorrect:** * **B. Pemphigus Vulgaris:** This is an autoimmune bullous disorder caused by antibodies against desmogleins. The mainstay of treatment is **systemic corticosteroids** and immunosuppressants (e.g., Azathioprine, Rituximab). * **C. Lupus Vulgaris:** This is a chronic form of cutaneous **Tuberculosis**. Treatment requires standard **Anti-Tubercular Therapy (ATT)** (Rifampicin, Isoniazid, etc.). * **D. Erythema Multiforme:** This is a hypersensitivity reaction (often triggered by HSV). Management involves treating the underlying cause and using supportive care or steroids; retinoids have no role here. **High-Yield Clinical Pearls for NEET-PG:** * **Teratogenicity:** Isotretinoin is highly teratogenic (Category X). Pregnancy must be ruled out, and "dual contraception" is mandatory (PPP - Pregnancy Prevention Programme). * **Monitoring:** Baseline and periodic checks of **Lipid profile** (risk of hypertriglyceridemia) and **Liver Function Tests (LFTs)** are essential. * **Side Effects:** The most common side effect is **Cheilitis** (dry lips). It is also associated with pseudotumor cerebri if taken with tetracyclines. * **Other indications for Retinoids:** Psoriasis (Acitretin), Ichthyosis, and Darier’s disease.
Explanation: **Explanation:** Oral isotretinoin is a systemic retinoid used for severe, nodulocystic, or recalcitrant acne. Because it is metabolized by the liver and significantly impacts lipid metabolism, baseline and periodic monitoring of specific laboratory parameters is mandatory. **Why Option B is Correct:** 1. **Liver Function Tests (LFTs):** Isotretinoin can cause a transient, dose-dependent increase in transaminases (ALT/AST). While usually mild, monitoring is essential to prevent hepatotoxicity. 2. **Lipid Profile:** Isotretinoin frequently causes **hypertriglyceridemia** (most common) and increased LDL levels. Severe hypertriglyceridemia (>800 mg/dL) poses a risk for acute pancreatitis; hence, a baseline lipid profile is critical. **Why Other Options are Incorrect:** * **Serum Electrolytes (Options A & C):** Isotretinoin does not affect renal function or electrolyte balance (sodium, potassium, etc.). * **Platelet Count (Option D):** While rare hematological changes (like mild leukopenia) can occur, they are not standard baseline requirements compared to LFTs and lipids. **High-Yield Clinical Pearls for NEET-PG:** * **Teratogenicity:** The most serious side effect. Female patients must follow the **iPLEDGE** program (or similar protocols), requiring two negative pregnancy tests before starting and two forms of contraception. * **Most Common Side Effect:** Cheilitis (dryness of lips). * **Musculoskeletal:** May cause myalgia and increased Creatine Phosphokinase (CPK) levels, especially in patients performing vigorous exercise. * **Psychiatric:** Though controversial, it is associated with mood swings and depression in some patients. * **Monitoring Frequency:** Usually checked at baseline, at 4 weeks, and then periodically if values are abnormal.
Explanation: ### Explanation **Correct Answer: D. Cyproterone Acetate** The clinical presentation of **moderate acne** associated with **irregular menses** in a teenage girl strongly suggests an underlying hormonal imbalance, most likely **Polycystic Ovary Syndrome (PCOS)**. In such cases, the acne is driven by hyperandrogenism. **Cyproterone acetate** is a potent anti-androgen that works by blocking androgen receptors and inhibiting 5-alpha reductase. When combined with ethinyl estradiol (as an oral contraceptive pill), it regulates the menstrual cycle and effectively treats hormonal acne by reducing sebum production. **Analysis of Incorrect Options:** * **A. Oral Isotretinoin:** Reserved for severe, nodulocystic, or scarring acne. While effective, it does not address the underlying hormonal trigger (irregular menses) and requires strict contraception due to teratogenicity. * **B. Oral Acitretin:** This is a second-generation retinoid used primarily for **psoriasis**. It is contraindicated in women of childbearing age due to its extremely long half-life and high teratogenic potential. * **C. Oral Minocycline:** An antibiotic used for inflammatory acne. While it helps reduce *C. acnes* colonization, it does not correct the hormonal dysfunction causing the irregular cycles. **Clinical Pearls for NEET-PG:** * **First-line for Hormonal Acne:** Combined Oral Contraceptive Pills (COCPs) or Spironolactone. * **SAHA Syndrome:** Consider this in females with **S**eborrhea, **A**cne, **H**irsutism, and **A**lopecia. * **Investigation of Choice:** If PCOS is suspected, order a USG (Pelvis/Abdomen) and check the LH:FSH ratio (typically >2:1 or 3:1). * **Key Side Effect:** Cyproterone acetate can cause weight gain, breast tenderness, and mood swings.
Explanation: **Explanation:** Acne vulgaris is a chronic inflammatory disease of the **pilosebaceous unit**. The primary structure involved is the **sebaceous gland**, which is responsible for the production of sebum. **Why Sebaceous Glands are Correct:** The pathogenesis of acne involves four key factors: 1. **Hyperseborrhea:** Excessive sebum production (stimulated by androgens). 2. **Follicular hyperkeratinization:** Plugging of the follicle (comedone formation). 3. **Colonization by *Cutibacterium acnes*:** An anaerobe that thrives in sebum. 4. **Inflammation:** Triggered by the release of free fatty acids and cytokines. Since sebum is the substrate for *C. acnes* and the source of the inflammatory cascade, the sebaceous gland is the central anatomical structure involved. **Why other options are incorrect:** * **Sweat glands:** These include eccrine and apocrine glands. Eccrine glands are involved in thermoregulation, while apocrine glands are involved in conditions like *Hidradenitis suppurativa*, not acne. * **Hair follicles:** While the follicle is part of the "pilosebaceous unit," the primary pathology originates from the gland's activity and the blockage of the duct. In acne, the hair itself is usually rudimentary (vellus hair). * **Ceruminous glands:** These are modified apocrine glands located in the external auditory canal that produce earwax. **High-Yield Clinical Pearls for NEET-PG:** * **Target Structure:** Pilosebaceous unit (specifically on the face, back, and chest where sebaceous glands are largest). * **First visible lesion:** Microcomedone. * **Hallmark lesion:** Comedones (Open = Blackheads; Closed = Whiteheads). * **Drug of Choice (Severe/Nodulocystic):** Oral Isotretinoin (the only drug that targets all four pathogenic factors). * **Common Association:** Polycystic Ovarian Syndrome (PCOS) in females with recalcitrant acne.
Acne Vulgaris: Pathophysiology
Practice Questions
Acne Vulgaris: Clinical Types
Practice Questions
Acne Vulgaris: Management
Practice Questions
Acne in Special Populations
Practice Questions
Rosacea
Practice Questions
Perioral Dermatitis
Practice Questions
Hidradenitis Suppurativa
Practice Questions
Acne Keloidalis Nuchae
Practice Questions
Acne Scarring and Its Management
Practice Questions
Psychological Aspects of Acne
Practice Questions
Diet and Acne
Practice Questions
Newer Therapies in Acne Management
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free